22Rv |
Antitumor assay |
50 mg/kg |
18 days |
Antitumor activity in GLI1 positive human 22Rv cells xenografted mouse model at 50 mg/kg, sc after 18 days |
17494766 |
NIH3T3 |
Function assay |
10 uM |
|
Inhibition of Hedgehog/Gli1 mediated transformation in mouse NIH3T3 cells at 10 uM |
17494766 |
PANC1 |
Function assay |
5 uM |
|
Reduction in GLI1 expression in human PANC1 cells at 5 uM |
17494766 |
PANC1 |
Function assay |
5 uM |
|
Reduction in PTCH expression in human PANC1 cells at 5 uM |
17494766 |
22Rv |
Function assay |
5 uM |
|
Reduction in GlI1 expression in human 22Rv cells at 5 uM |
17494766 |
22Rv |
Function assay |
5 uM |
|
Reduction in PTCH expression in human 22Rv cells at 5 uM |
17494766 |
HEK293 |
Function assay |
30 uM |
|
Inhibition of GLI (unknown origin) expressed in HEK293 cells assessed as reduction in GLI-mediated transcription at 30 uM |
25581017 |
TM3 |
Function assay |
|
48 hrs |
Inhibition of Hh signaling pathway in mouse TM3 cells assessed as downregulation of Gli1 gene expression after 48 hrs by luciferase reporter gene assay, EC50 = 9.27 μM. |
26976215 |
HeLa |
Function assay |
|
4.5 hrs |
Inhibition of Ebolavirus glycoprotein/matrix protein VP40 entry in human HeLa cells after 4.5 hrs beta-lactamase reporter assay, IC50 = 6.83 μM. |
29624387 |
Rh30 |
Function assay |
|
24 hrs |
Inhibition of human Gli1-mediated transcriptional activity in human Rh30 cells after 24 hrs by luciferase reporter gene assay, IC50 = 40 μM. |
20605720 |
SK-N-DZ |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human SK-N-DZ cells after 72 hrs by fluorometric microculture cytotoxicity assay, GI50 = 5.82 μM. |
ChEMBL |
SK-N-SH |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human SK-N-SH cells after 72 hrs by fluorometric microculture cytotoxicity assay, GI50 = 5.82 μM. |
ChEMBL |
SK-N-FI |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human SK-N-FI cells after 72 hrs by fluorometric microculture cytotoxicity assay, GI50 = 5.82 μM. |
ChEMBL |
SK-N-AS |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human SK-N-AS cells after 72 hrs by fluorometric microculture cytotoxicity assay, GI50 = 5.82 μM. |
ChEMBL |
IMR32 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human IMR32 cells after 72 hrs by fluorometric microculture cytotoxicity assay, GI50 = 5.82 μM. |
ChEMBL |
SK-N-BE(2) |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human SK-N-BE(2) cells after 72 hrs by fluorometric microculture cytotoxicity assay, GI50 = 5.82 μM. |
ChEMBL |
SH-SY5Y |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human SH-SY5Y cells after 72 hrs by fluorometric microculture cytotoxicity assay, GI50 = 5.82 μM. |
ChEMBL |
NIH 3T3 |
Function assay |
|
|
Inhibition of Hh signaling pathway in Shh-LIGHT2 incorporated mouse NIH 3T3 cells assessed as downregulation of Gli1 gene expression by luciferase reporter gene assay, EC50 = 5 μM. |
26976215 |
Shh-L2 |
Function assay |
|
|
Inhibition of Hedgehog signaling in human Shh-L2 cells, IC50 = 5 μM. |
17494766 |
Shh Light2 |
Function assay |
|
|
Inhibition of SHH in mouse Shh Light2 cells by GLI-responsive firefly luciferase reporter gene assay, IC50 = 5 μM. |
19309080 |
HEK293 |
Function assay |
|
|
Reduction of GLI2 mediated transcription in HEK293 cells by luciferase reporter assay |
17494766 |
NIH3T3 |
Function assay |
|
|
Inhibition of GLI1 induced hedgehog signaling in mouse NIH3T3 cells |
17494766 |
HEK293 |
Function assay |
|
|
Inhibition of beta galactosidase in HEK293 cells |
17494766 |
MEF |
Function assay |
|
|
Reduction in expression of Hedgehog target gene Hip1 in Sufu deficient mouse MEF cells |
17494766 |
22Rv |
Function assay |
|
|
Reduction of expression of PTCH mRNA in human 22Rv cells |
17494766 |
HEK293 |
Function assay |
|
|
Inhibition of nuclear accumulation of GLI mutant in HEK293 cells |
17494766 |
HEK293 |
Function assay |
|
|
Inhibition of nuclear accumulation of wild type GLI in HEK293 cells |
17494766 |
HEK293 |
Function assay |
|
|
Reduction of GLI1 mediated transcription in HEK293 cells by luciferase reporter assay |
17494766 |
A673 |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells |
29435139 |
SK-N-MC |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells |
29435139 |
NB-EBc1 |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells |
29435139 |
OHS-50 |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells |
29435139 |
RD |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells |
29435139 |